The latest update is out from Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ).
Dawnrays Pharmaceutical Holdings Ltd. has announced a final cash dividend of HKD 0.048 per share for the year ending December 31, 2024. This announcement reflects the company’s financial performance and commitment to returning value to its shareholders. The dividend will be paid on June 12, 2025, following shareholder approval on May 23, 2025. This decision may influence investor sentiment and affect the company’s stock performance in the market.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacture, and sale of pharmaceutical products. The company primarily targets the healthcare market with its range of medications and treatments.
YTD Price Performance: 3.28%
Average Trading Volume: 171,535
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.89B
For detailed information about 2348 stock, go to TipRanks’ Stock Analysis page.